Does your state have legal cannabis?
Yes! On February 2, 2022, Gov. Tate Reeves (R) signed into law the Mississippi Medical Cannabis Act (SB 2095), sponsored by Sen. Kevin Blackwell, to restore voters’ will by creating a medical cannabis program.
Where to start?
Our certification programs span from Washington state to New York, and every legal state in between. The Medical Cannabis Foundational Certification will allow you to learn the core fundamentals of cannabis science and explore cannabis industry knowledge, so you are prepared to be a certified hire, as medical cannabis is legalized in your state. Our courses and certifications will provide you with knowledge and skillset to enter the cannabis job market competitively, right out of the gate.
Get certified by the best cannabis education company, Medical Marijuana 411 (MM411 Inc).
What does the Medical Cannabis Foundational Certification Include?
The Medical Cannabis Foundational Certification will allow you to learn the core fundamentals of cannabis science and explore cannabis industry knowledge, so you are prepared to be a certified in your state. Our courses and certifications will provide you with knowledge and skillset to enter the cannabis job market competitively, right out of the gate. This certification is not just for medical professionals, but for budtenders who want to enroll in the most robust cannabis certification course as your educational foundation.
As you expand your cannabis educational pursuits, make sure to check out additional courses such as our Continuing Courses or Advanced CBD Certification. Medical Marijuana 411 will be adding new expert level certifications monthly. Subscribe to our e-news to stay informed!
The Medical Cannabis Foundational Course is an online course that covers a series of 12 modules designed to teach healthcare and industry professionals the fundamental topics of cannabis and includes a specific module on the legal framework, forms and other pertinent information regarding the Minnesota Office of Medical Cannabis Regulations.
In addition to Mississippi specific regulations, the history behind the groundbreaking, “Harper Grace’s Law,” learn about the federal legal framework of working with medical marijuana patients, the basics of the cannabis plant, the Endocannabinoid System, and how cannabinoid receptors work with our bodies. Additional modules will cover important topics like: how to medicate, inhalation versus ingestion, contraindications, drug-on-drug interactions, and recommended rations of specific illnesses.
Did you know that Healthcare Professionals are covered by Federal Law to talk to patients about Medical Marijuana even in non-legal states by an existing statute? That’s the wealth of information contained in MM411, Inc. certifications.
This certification also includes: video testimonials from scientists and medical experts, downloadable infographics, additional visuals to support the written content followed by an exam to receive your certificate. Any individual wanting to learn more about the science of cannabis will find the course valuable. And we guarantee your complete satisfaction or your money back. To date, MM411, Inc has never had a return. Enrollees love our certifications and we stand by our courses with a 100% guarantee.
If you are a dispensary, medical group, or company and interested in multi-seat pricing or a customized, white label course, please call 844.411.0500.
Mississippi – Medical Marijuana Legal Overview
Mississippi legislators recently passed a bill to allow medical cannabis access in the state. There are no provisions for personal cultivation by patients or caregivers. Patients will be allowed a monthly allotment of 3 ounces but will only be allowed to purchase a single 1/8th per day from state licensed retailers. This means to meet their monthly allotment, they would have to make 24 separate trips to the dispensary. Licenses are set to be awarded in August 2022, but zoning restrictions and heavy local control are likely to severely impact where businesses can operate.
Any physician who is licensed to practice medicine in Mississippi may issue a written order for CBD oil treatment to patients suffering with a debilitating epileptic condition or related illness. The CBD oil must be administered by or under the direction or supervision of that physician.
Despite being the home of the National Institute on Drug Abuse’s only facility where cannabis was once grown by the federal government, patients in Mississippi still face tremendous access problems. In 2014, Mississippi enacted HB 1231, which creates an affirmative defense for the possession and use of CBD oil solely for patients who suffer from debilitating epilepsy. Known as “Harper Grace’s Law,” the bill only provides legal protections to this extremely limited patient population only if the CBD oil was either obtained from or tested by the National Center for Natural Products Research at the University of Mississippi, and dispensed by the Department of Pharmacy Services at the University of Mississippi Medical Center. The law requires that CBD oil must have at least 15 percent CBD and no more than 0.5 percent THC. In 2017, the legislature passed SB 2610, which clarifies the use of CBD in research for the treatment of seizures. The Hospitality State decriminalized possession of small amounts of cannabis in 1979, penalizing first-offenders of 30 grams or less with a $250 fine rather than imprisonment.
Source: Americans for Safe Access
Mississippi is one of the 31 states that have decriminalized — or, in 18 cases, legalized — personal-use cannabis possession. First offense possession of 30 grams (a little more than an ounce) is punishable by a $250 fine instead of jail time and a civil summons as opposed to arrest, as long as the offender provides proof of identity and a written promise to appear in court. However, Mississippi’s cannabis law has a gaping loophole: possession of paraphernalia — such as the baggie cannabis is in — remains a criminal offense punishable by up to six months. Source: MPP
Mississippi-licensed physicians, certified nurse practitioners, physician assistants, and optometrists may sign written certifications for conditions within their scope of practice for medical cannabis if they:
- believe the patient “would likely receive medical or palliative benefit” from medical cannabis to treat their qualifying condition;
- have performed an in-person assessment of the patient;
- perform a follow-up within six months to evaluate the effectiveness; and
- have completed eight hours of continuing medical education courses on medical cannabis, plus five hours every year thereafter.
The practitioner writing the certification must also diagnose the patient with the qualifying condition. Those written certifications must be issued on forms approved by the Mississippi Department of Health.
- Amyotrophic lateral sclerosis
- Autism with aggressive behaviors
- Crohn’s disease
- Dementia-related agitation
- Huntington’s disease
- Intractable nausea
- Intractable seizures
- Multiple sclerosis and/or severe muscle spasticity
- Opioid management
- Parkinson’s disease
- Post-traumatic stress disorder
- Severe chronic or intractable pain
- Spinal cord damage
- Sickle cell anemia
- Terminal illness
- Ulcerative colitis
Module 1 – US Legal
- U.S. Controlled Substances Act
- Drug Schedule – Cannabis Schedule I
- Drug Schedule (Graphic)
- COVID Cannabis Guidelines
- Economic Impact
- Cannabis genus of flowering plants in the family Cannabaceae
- Legal differentiation between hemp and marijuana distinguished by their respective concentrations of the cannabinoid delta-9 tetrahydrocannabinol (THC)
- 2018 Farm Bill
- Impact on hemp classification
- SAFE Banking Act
- U.S. Pat. No. 6,630,507
- Ogden Memo
- Cole Memo
- Wilkenson Memo
- 2018 Sessions Memorandum
- Rohrabacher–Blumenauer Amendment
- Joyce Amendment
- Conant v. Walters
- What Medical Professionals Can Legally Provide To Their Patients (Graphic)
- Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research
- Guidance for Industry – Downloadable PDf
- Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research
- Guidance for Industry – Video Explainer
- Affirmative Defense
- Bankruptcy Protection
- Employment Law
- Access to Banking – Financial Crimes Enforcement Network FinCEN Guidance
- Copyright and Registration
Module 2 – Mississippi Medical Cannabis Legal including the legal history of “Harper Grace’s Law,”
Module 3 – History
- Early History of Cannabis Use
- Cannabis in the West
- U.S. Prohibition History
- The Medical Implications of U.S. Prohibition
- Medical Cannabis Today
- Hemp vs Cannabis
- Brief Chronology of History in Spain and throughout Europe
Module 4 – The Discovery of the Endocannabinoid System
- Introduction of the Endocannabinoid System (ECS)
- Largest Receptor System
- ECS – Video Explainer
- Newly Discovered
- Chemical Bridge to All Bodily Functions
- Healthy Body = Healthy ECS
- ECS – Downloadable Graphic
- Dr Jake Felice – What is the Endocannabinoid System (ECS)? Video Interview
- Largest Neurotransmitter System of all “the body’s supercomputer”
- 1964 discovery of THC and CBD – Raphael Mechoulam, Ph.D and Yehiel Gaoni, Ph.D
- The Scientist – video regarding Raphael Mechoulam, Ph.D discoveries
- Allyn Howlett, Ph.D – Isolating THC in the brain – 1998
- No cannabinoid receptors in the cardiac and respiratory centers of the brainstem therefore no overdose from cannabis
- Raphael Mechoulam, Ph.D found in 1992, brain chemical that mirrors the effects of THC
- Two brain chemicals – anandamide, Sanskrit word “ananda” brain chemical that mimics THC and CBD, 2-Arachidonoylglycerol, which they named 2-AG.
- Endogenous Molecules “endocannabinoids”.
- CB1 receptors, and CB2 receptors
- Cannabinoids and how they attach to receptors
- CB1 receptors
- Located in the central nervous system and affect many brain functions including movement, anxiety, stress, fear, pain, appetite, reward, and motor control
- CB2 receptors
- CB2 receptors control the release of cytokines, immuno-regulatory proteins, that are linked to inflammation during illness or after injury.
- Retrograde Inhibition
- Lack of education on the Endocannabinoid System
- Clinical Studies
- At a Glance – Downloadable Infographic
- Human Thriving Behavior and the ECS
Module 5 – One Plant, One Complex Chemical Factory
- Minor Cannabinoids: CBG CBC CBN THCV
- The Entourage Effect & Tolerance / ECS Down Regulation
- Botanical vs. Single Molecule Compounds & Cannabinoids and Opioids
Module 6 – Getting Cannabinoids into the Bloodstream
- Inhalation: Smoking vs. Vaporization
- In the News Discussions
- Cannabis Flower vs. Concentrate
- Different Concentrate Consistencies
- Extraction Methods
- Concentrates Using Solvents
- Solventless Concentrates
- Edibles, Oral Mucosal, Topicals and Suppositories
- The Role of the Medical Provider
- The Role of the Dispensary: Experts within the Dispensary
Module 7 – Patient Centered Dosing
- Considerations Before Medicating with Cannabis
- Set and Setting
- Drug-Drug Interactions
- Relative Contraindications
- Youth Under 25
- Patients and Cardiac Conditions
- Patients with Psychiatric Diagnoses
- Immunocompromised Patents
- Biphasic Effect
- Finding the Appropriate Dose
- Recommended Ratios for Specific Illnesses
Module 8 – Laboratory Testing
- How Testing Works
- Contaminants: Pesticides, Fungi and Mold
- How to Interpret a Test
Module 9 – Clinical Practice
- Anxiety Disorders
- Gastrointestinal Disorders
- Migraine Headaches
- Multiple Sclerosis
- Neurodegenerative Disorders
- Palliative Care
- Parkinson’s Disease
- Post Traumatic Stress Disorders
- Sleep Disorders
- Traumatic Brain Injury (TBI)
- Premenstrual Syndrome and Premenstrual Dysphoric Disorder
Module 10 – Cannabis and Opioids
- Pain Management Today
- Cannabis and Opioids: The Good News
- Cannabis and NSAIDS: More Good News
Module 11 – Medical Myths and Facts
- Gateway Theory, Addiction and Brain Function
- Impaired Motivation, Memory and Mental State
- Lung Damage, Usage Patterns and Overall Danger
Module 12 – Side Effects Abuse and Misuse
- Cannabinoid Hyperemesis Syndrome
- Cannabis Use Disorder (CUD)
- Short and Long Term Side Effects
- Physical and Mental Effects
- Cannabis and driving
- Cannabis Overconsumption and Tolerance